Definium Therapeutics
DFTX
135 hedge funds and large institutions have $327M invested in Definium Therapeutics in 2024 Q1 according to their latest regulatory filings, with 46 funds opening new positions, 31 increasing their positions, 17 reducing their positions, and 13 closing their positions.
1,724% more capital invested
Capital invested by funds: $18M → $327M (+$310M)
364% more call options, than puts
Call options by funds: $28.4M | Put options by funds: $6.11M
300% more funds holding in top 10
Funds holding in top 10: 1 → 4 (+3)
254% more first-time investments, than exits
New positions opened: 46 | Existing positions closed: 13
82% more repeat investments, than reductions
Existing positions increased: 31 | Existing positions reduced: 17
72.01% more ownership
Funds ownership: 12.24% → 84.24% (+72%)
30% more funds holding
Funds holding: 104 → 135 (+31)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DTC
Deep Track Capital
Greenwich,
Connecticut
|
+$38M |
| 2 |
CC
Commodore Capital
New York
|
+$33.3M |
| 3 |
DCM
Driehaus Capital Management
Chicago,
Illinois
|
+$14.5M |
| 4 |
OCA
Octagon Capital Advisors
New York
|
+$12.3M |
| 5 |
GPP
Great Point Partners
Greenwich,
Connecticut
|
+$11.4M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
IC
Ikarian Capital
Dallas,
Texas
|
-$1.72M |
| 2 |
BB
Busey Bank
Urbana,
Illinois
|
-$572K |
| 3 |
CAM
Cresset Asset Management
Chicago,
Illinois
|
-$565K |
| 4 |
Group One Trading
Chicago,
Illinois
|
-$422K |
| 5 |
SC
Scotia Capital
Toronto,
Ontario, Canada
|
-$387K |
DFTX Hedge Fund Activity: Q1 2024 in Review
135 of the 6,942 institutional investors tracked by Wall St. Rank reported a position in Definium Therapeutics (DFTX) for Q1 2024, worth a combined $327M — up 1,724% from $18M a quarter earlier.
Buyers outnumbered sellers: 46 funds opened new DFTX positions and 13 closed out — a net gain of 33 holders — while 31 added to existing stakes and 17 trimmed.
The largest buyer was Deep Track Capital, opening a new position worth an estimated $38M. The largest seller was Ikarian Capital, cutting an estimated $1.72M.
- 135 institutional investors held Definium Therapeutics (DFTX) as of Q1 2024, up from 104 in Q4 2023.
- Funds reported $327M of Definium Therapeutics stock for Q1 2024, up 1,724% quarter-over-quarter.
- 46 funds opened new Definium Therapeutics positions in Q1 2024 and 13 closed out, a net change of +33 holders.
- The largest Definium Therapeutics buyer in Q1 2024 was Deep Track Capital, an estimated $38M added.
- The largest Definium Therapeutics seller in Q1 2024 was Ikarian Capital, an estimated $1.72M sold.
Based on aggregated 13F filings for Q1 2024.